Radiofrequency Ablation: A Minimally Invasive Approach in Kidney Tumor Management
AbstractThe management and diagnosis of renal tumors have changed significantly over the last decade. Due to advances in imaging techniques, more than 50% of kidney tumors are discovered incidentally and many of them represent an early stage lesion. This has stimulated the development of nephron-sparing surgery and of the minimally invasive treatment options including ablative techniques, i.e., radiofrequency ablation (RFA) and cryoablation. The objective of the minimally invasive approach is to preserve the renal function and to lower the perioperative morbidity. RFA involves inducing the coagulative necrosis of tumor tissue. Being probably one of the least invasive procedures in kidney tumor management, RFA may be performed percutaneously under ultrasound (US), computed tomography (CT) or magnetic resonance (MR) guidance. Most of the studies show that the RFA procedure is efficient, safe and has a low complication rate. Due to the still limited data on the oncological outcome of RFA, the indication for this intervention remains limited to selected patients with small organ-confined renal tumors and contraindication to surgery or who have a solitary kidney. The aim of our study is to review the literature on RFA of kidney tumors.
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Salagierski, M.; Salagierski, M.S. Radiofrequency Ablation: A Minimally Invasive Approach in Kidney Tumor Management. Cancers 2010, 2, 1895-1900.
Salagierski M, Salagierski MS. Radiofrequency Ablation: A Minimally Invasive Approach in Kidney Tumor Management. Cancers. 2010; 2(4):1895-1900.Chicago/Turabian Style
Salagierski, Maciej; Salagierski, Marek S. 2010. "Radiofrequency Ablation: A Minimally Invasive Approach in Kidney Tumor Management." Cancers 2, no. 4: 1895-1900.